MANIPULATION OF GENE EXPRESSION WITH SMALL MOLECULES
用小分子操纵基因表达
基本信息
- 批准号:8147684
- 负责人:
- 金额:$ 28.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2012-05-09
- 项目状态:已结题
- 来源:
- 关键词:AnimalsBindingBiological AssayBiomedical ResearchCellsCellular AssayCharacteristicsChromatinCollaborationsCultured CellsDiabetes MellitusGene ChipsGene ExpressionGene TargetingGenerationsGenesGoalsHandHoloenzymesHuman Cell LineIn VitroIsocitrate DehydrogenaseLaboratoriesLeadLibrariesLifeLinkMapsMeasuresMetabolismNuclear ExtractNylonsPeptoidsPermeabilityPrincipal InvestigatorPromoter RegionsPropertyProteinsRNA Polymerase IIRecruitment ActivityReportingSpecificitySynthetic GenesTherapeutic AgentsTransactivationWorkbasechromatin immunoprecipitationcombinatorialdesigngenome-widehuman CREB1 proteinimprovedisletnovelprogramspromoterresearch studysmall moleculetooltranscription factor
项目摘要
The goal of this project is to create cell permeable synthetic molecules capable of activating the expression of specific genes. The "synthetic transcription factor mimics" would be capable of localizing to a specific promoter region and recruiting the transcriptional machinery to a nearby gene, thus mimicking a basic function of native transactivator proteins. These molecules would be tools of outstanding utility in biomedical research and could potentially be elaborated into a new class of therapeutic agents.
It is envisioned that a synthetic activator could be created by fusing together a DMA-binding molecule, specifically a hairpin polyamide with the appropriate DMA recognition characteristics, with a molecule capable of binding the RNA polymerase II holoenzyme, thus recruiting it to the target promoter. There is considerable evidence from our laboratory and others that this is a valid approach, but while synthetic activators capable of functioning in nuclear extracts have been reported, the goal of molecules that function
in living cells remains elusive. We have recently made an exciting breakthrough with the discovery of a cell permeable peptoid that functions as an activation domain equivalent in living cells. This is the first observation of such activity. We plan to link this peptoid and improved derivatives to hairpin polyamides with appropriate sequence recognition properties to create cell permeable synthetic activators. These compounds will be employed to manipulate metabolism in cell lines and human islets. In particular, we will
attempt to activate the Nkx6.1 gene and the cytosolic, NADPH-dependent isocitrate dehydrogenase gene in islets and determine the effect of this stimulation of the metabolism of the cell. These studies will be in collaboration with the Newgard laboratory. Following the lead of recent results in the Newgard laboratory, we also plan to use genome-wide chromatin immunoprecipitation assays to help to identify direct Nkx6.1 target
genes and will also then design synthetic molecules to turn on these genes as well.
Throughout the course of this project, consistent efforts will be made to develop ever more potent synthetic activators. To do so, we will take advantage of a novel cell-based screen that we have developed which allows synthetic combinatorial libraries to be screened for activation domain mimics directly.
Furthermore, we will also set up cellular assays to optimize polyamides for binding to the desired promoters.
该项目的目标是创造能够激活特定基因表达的细胞渗透性合成分子。 “合成转录因子模拟物”将能够定位到特定的启动子区域并将转录机制招募到附近的基因,从而模拟天然反式激活蛋白的基本功能。这些分子将成为生物医学研究中具有突出用途的工具,并有可能被精心制作成一类新型治疗剂。
据设想,可以通过将 DMA 结合分子(特别是具有适当 DMA 识别特性的发夹聚酰胺)与能够结合 RNA 聚合酶 II 全酶的分子融合在一起,从而将其招募到目标启动子来创建合成激活剂。我们的实验室和其他实验室有大量证据表明这是一种有效的方法,但是虽然已经报道了能够在核提取物中发挥作用的合成激活剂,但发挥作用的分子的目标
在活细胞中仍然难以捉摸。我们最近取得了令人兴奋的突破,发现了一种可渗透细胞的类肽,其功能相当于活细胞中的激活域。这是首次观察到此类活动。我们计划将这种类肽和改进的衍生物连接到具有适当序列识别特性的发夹聚酰胺,以创建细胞可渗透的合成激活剂。这些化合物将用于操纵细胞系和人类胰岛的新陈代谢。特别是,我们将
尝试激活胰岛中的 Nkx6.1 基因和胞质 NADPH 依赖性异柠檬酸脱氢酶基因,并确定这种刺激对细胞代谢的影响。这些研究将与纽加德实验室合作。继 Newgard 实验室最新结果的引领下,我们还计划使用全基因组染色质免疫沉淀测定来帮助识别直接的 Nkx6.1 靶点
基因,然后还将设计合成分子来打开这些基因。
在该项目的整个过程中,我们将不断努力开发更有效的合成活化剂。为此,我们将利用我们开发的一种新型的基于细胞的筛选,该筛选允许直接筛选合成组合文库的激活域模拟物。
此外,我们还将建立细胞测定法来优化聚酰胺与所需启动子的结合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas J. Kodadek其他文献
Thomas J. Kodadek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas J. Kodadek', 18)}}的其他基金
Establishment of a Cell-Based Screening Platform for DNA Encoded Libraries
DNA编码文库细胞筛选平台的建立
- 批准号:
10646635 - 财政年份:2023
- 资助金额:
$ 28.34万 - 项目类别:
Molecular Cloaking Devices for Manipulation of Cysteine Post-Translational Modifications
用于操纵半胱氨酸翻译后修饰的分子隐藏装置
- 批准号:
10507541 - 财政年份:2022
- 资助金额:
$ 28.34万 - 项目类别:
Phenotypic screening using DNA-encoded libraries
使用 DNA 编码文库进行表型筛选
- 批准号:
10238888 - 财政年份:2018
- 资助金额:
$ 28.34万 - 项目类别:
Phenotypic screening using DNA-encoded libraries
使用 DNA 编码文库进行表型筛选
- 批准号:
10622655 - 财政年份:2018
- 资助金额:
$ 28.34万 - 项目类别:
Phenotypic screening using DNA-encoded libraries
使用 DNA 编码文库进行表型筛选
- 批准号:
10001013 - 财政年份:2018
- 资助金额:
$ 28.34万 - 项目类别:
Discovery of Potent Proteasome Agonists to Improve Proteostasis
发现有效的蛋白酶体激动剂以改善蛋白质稳态
- 批准号:
9388111 - 财政年份:2017
- 资助金额:
$ 28.34万 - 项目类别:
Discovery of antibody biomarkers for Alzheimer’s Disease
阿尔茨海默病抗体生物标志物的发现
- 批准号:
9092101 - 财政年份:2016
- 资助金额:
$ 28.34万 - 项目类别:
Discovery of antibody biomarkers for Alzheimer’s Disease
阿尔茨海默病抗体生物标志物的发现
- 批准号:
9265411 - 财政年份:2016
- 资助金额:
$ 28.34万 - 项目类别:
HTS for Direct Targeting of the Transcription Factor MITF
用于直接靶向转录因子 MITF 的 HTS
- 批准号:
9109569 - 财政年份:2014
- 资助金额:
$ 28.34万 - 项目类别:
Discovery and Treatment of the Early Autoimmune Reaction In Type 1 Diabetes
1 型糖尿病早期自身免疫反应的发现和治疗
- 批准号:
8240614 - 财政年份:2011
- 资助金额:
$ 28.34万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
利用分子装订二硫键新策略优化改造α-芋螺毒素的研究
- 批准号:82104024
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CST蛋白复合体在端粒复制中对端粒酶移除与C链填补调控的分子机制研究
- 批准号:31900521
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
Wdr47蛋白在神经元极化中的功能及作用机理的研究
- 批准号:31900503
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 28.34万 - 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 28.34万 - 项目类别:
Involvement of dopamine signaling in chronic pain-induced negative affective state and nicotine use comorbidity
多巴胺信号传导参与慢性疼痛引起的负面情感状态和尼古丁使用合并症
- 批准号:
10662951 - 财政年份:2023
- 资助金额:
$ 28.34万 - 项目类别:
Developing an integrated pipeline for routine generation of orthogonal GPCR-targeting nanobodies
开发用于常规生成正交 GPCR 靶向纳米抗体的集成管道
- 批准号:
10603669 - 财政年份:2023
- 资助金额:
$ 28.34万 - 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
- 批准号:
10604822 - 财政年份:2023
- 资助金额:
$ 28.34万 - 项目类别: